Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 21, 2024International Journal of Hematology-Oncology and Stem Cell ResearchOpen Access

Comparison of Cyclophosphamide-Based Graft Versus Host Disease Prophylaxis after “Allogeneic Stem Cell Transplantation from 9/10HLA Matched Unrelated Donor’’ with Standard Graft Versus Host Disease Prophylaxis after “10/10HLA Matched Relative Donor’’

View Full Paper
Ask AI
Bookmark
Share

Authors

MYMurat YıldırımMemorial Ankara HospitalSSSelim SayınGülhane Askerî Tıp AkademisiMCMelda CömertBezmiâlem Vakıf Üniversitesi

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yıldırım et al. (2024) studied this question.

synapsesocial.com/papers/68e5f940b6db64358758deb5https://doi.org/10.18502/ijhoscr.v18i3.16103
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide2008 · 1,951 citations
  2. 2Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT2018 · 191 citations
  3. 3<scp>OCTET</scp>‐<scp>CY</scp>: a phase <scp>II</scp> study to investigate the efficacy of post‐transplant cyclophosphamide as sole graft‐versus‐host prophylaxis after allogeneic peripheral blood stem cell transplantation2015 · 67 citations
  4. 4Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation2020 · 40 citations
  5. 5High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease2010 · 407 citations